BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 26443474)

  • 21. Dual in vivo photoacoustic and fluorescence imaging of HER2 expression in breast tumors for diagnosis, margin assessment, and surgical guidance.
    Maeda A; Bu J; Chen J; Zheng G; DaCosta RS
    Mol Imaging; 2014; 13():. PubMed ID: 25430722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.
    Steffensen KD; Waldstrøm M; Andersen RF; Olsen DA; Jeppesen U; Knudsen HJ; Brandslund I; Jakobsen A
    Int J Oncol; 2008 Jul; 33(1):195-204. PubMed ID: 18575766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH triggered in vivo photothermal therapy and fluorescence nanoplatform of cancer based on responsive polymer-indocyanine green integrated reduced graphene oxide.
    Sharker SM; Lee JE; Kim SH; Jeong JH; In I; Lee H; Park SY
    Biomaterials; 2015 Aug; 61():229-38. PubMed ID: 26005762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between growth factor heregulin1α and receptors in growth of ovarian cancer cell line with high potentiality of peritoneal dissemination.
    Nishiyama H; Soeda S; Watanabe T; Fujimori K
    Fukushima J Med Sci; 2012; 58(1):22-32. PubMed ID: 22790889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells.
    zum Büschenfelde CM; Hermann C; Schmidt B; Peschel C; Bernhard H
    Cancer Res; 2002 Apr; 62(8):2244-7. PubMed ID: 11956077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer.
    Wittinger M; Vanhara P; El-Gazzar A; Savarese-Brenner B; Pils D; Anees M; Grunt TW; Sibilia M; Holcmann M; Horvat R; Schemper M; Zeillinger R; Schöfer C; Dolznig H; Horak P; Krainer M
    Clin Cancer Res; 2011 Dec; 17(24):7816-27. PubMed ID: 22016507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
    Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
    Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silica-gold nanoshells as potential intraoperative molecular probes for HER2-overexpression in ex vivo breast tissue using near-infrared reflectance confocal microscopy.
    Bickford LR; Agollah G; Drezek R; Yu TK
    Breast Cancer Res Treat; 2010 Apr; 120(3):547-55. PubMed ID: 19418216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives.
    Toyota T; Fujito H; Suganami A; Ouchi T; Ooishi A; Aoki A; Onoue K; Muraki Y; Madono T; Fujinami M; Tamura Y; Hayashi H
    Bioorg Med Chem; 2014 Jan; 22(2):721-7. PubMed ID: 24393719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer.
    Cai Y; Wang J; Zhang L; Wu D; Yu D; Tian X; Liu J; Jiang X; Shen Y; Zhang L; Ren M; Huang P
    Med Oncol; 2015 Jan; 32(1):391. PubMed ID: 25433947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342).
    Zhang J; Zhao X; Wang S; Wang N; Han J; Jia L; Ren X
    Nucl Med Biol; 2015 Jun; 42(6):541-6. PubMed ID: 25735223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virus-mimicking nano-constructs as a contrast agent for near infrared photoacoustic imaging.
    Gupta S; Chatni MR; Rao AL; Vullev VI; Wang LV; Anvari B
    Nanoscale; 2013 Mar; 5(5):1772-6. PubMed ID: 23334567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A molecularly targeted theranostic probe for ovarian cancer.
    Chen W; Bardhan R; Bartels M; Perez-Torres C; Pautler RG; Halas NJ; Joshi A
    Mol Cancer Ther; 2010 Apr; 9(4):1028-38. PubMed ID: 20371708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocyte-Derived Optical Nanoprobes Doped with Indocyanine Green-Bound Albumin: Material Characteristics and Evaluation for Cancer Cell Imaging.
    Mac JT; Vankayala R; Patel DK; Wueste S; Anvari B
    ACS Biomater Sci Eng; 2018 Aug; 4(8):3055-3062. PubMed ID: 33435025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Near Infrared Fluorescence Imaging of Intraperitoneal Ovarian Tumors in Mice Using Erythrocyte-Derived Optical Nanoparticles and Spatially-Modulated Illumination.
    Burns JM; Shafer E; Vankayala R; Kundra V; Anvari B
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34067308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.
    van Dam GM; Themelis G; Crane LM; Harlaar NJ; Pleijhuis RG; Kelder W; Sarantopoulos A; de Jong JS; Arts HJ; van der Zee AG; Bart J; Low PS; Ntziachristos V
    Nat Med; 2011 Sep; 17(10):1315-9. PubMed ID: 21926976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micellar formulation of indocyanine green for phototherapy of melanoma.
    Mundra V; Peng Y; Rana S; Natarajan A; Mahato RI
    J Control Release; 2015 Dec; 220(Pt A):130-140. PubMed ID: 26482083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virus-like nanoparticles as a theranostic platform for cancer.
    Kim KR; Lee AS; Kim SM; Heo HR; Kim CS
    Front Bioeng Biotechnol; 2022; 10():1106767. PubMed ID: 36714624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of nanoencapsulation of ICG on two-photon bioimaging.
    Kumari A; Kumari K; Gupta S
    RSC Adv; 2019 Jun; 9(32):18703-18712. PubMed ID: 35515210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linalool-Loaded Glutathione-Modified Gold Nanoparticles Conjugated with CALNN Peptide as Apoptosis Inducer and NF-κB Translocation Inhibitor in SKOV-3 Cell Line.
    Jabir M; Sahib UI; Taqi Z; Taha A; Sulaiman G; Albukhaty S; Al-Shammari A; Alwahibi M; Soliman D; Dewir YH; Rizwana H
    Int J Nanomedicine; 2020; 15():9025-9047. PubMed ID: 33235450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.